Last edition
News about "Rare Pediatric Disease"
Accro Bioscience's AC-101 Enters NMPA Rare Disease Development Pilot Program
Accro Bioscience’s AC-101, a novel selective RIPK2 inhibitor, enters the NMPA CDE Caring Plan-Extension pilot program for rare disease drug development.
Rare Pediatric Disease | 14/09/2026 | By News Bureau | 107
Aardvark Therapeutics Secures USD 85 Million Oversubscribed Series C Financing
Aardvark Therapeutics, Inc. has received an USD 85 million oversubscribed Series C financing led by Decheng Capital.
Rare Pediatric Disease | 10/05/2024 | By Aishwarya | 588
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy